The plant species were collected in Sudan (Blue Nile Forest, Ed Damazin Forestry areas) and selected according to their uses in traditional medicine for the treatment of bacterial infections, including TB. Eighty extracts and fractions of the stem bark, stem wood, roots, leaves and fruits of T. laxiflora and T. brownii and nine pure compounds present in the active extracts were screened against Mycobacterium smegmatis ATCC 14468 using agar diffusion and microplate dilution methods. Inhibition zones and MIC values were estimated and compared to rifampicin. HPLC-UV/DAD, GC/MS and UHPLC/Q-TOF MS were employed to identify the compounds in the growth inhibitory extracts.
Results:
The roots of T. laxiflora and T. brownii gave the best antimycobacterial effects against Mycobacterium smegmatis. The lowest MIC of 625µg/ml was observed for an acetone extract of the root of T. laxiflora followed by methanol and ethyl acetate extracts, both giving MIC values of 1250 µg/ml. Sephadex LH-20 column chromatography purification of T. brownii roots resulted in low MIC values of 62.5 µg/ml and 125 µg/ml for acetone and ethanol fractions, respectively, compared to 5000 µg/ml for the crude methanol extract. Methyl (S)-flavogallonate is suggested to be the main active compound in the Sephadex LH-20 acetone fraction, while ellagic acid xyloside and methyl ellagic acid xyloside are suggested to give good antimycobacterial activity in the Sephadex LH-20 ethanol fraction. RP-18 TLC purifications of an ethyl acetate extract of T. laxiflora roots resulted in the enrichment of punicalagin in one of the fractions (Fr5). This fraction gave a five times smaller MIC (500 µg/ml) than the crude ethyl acetate extract (2500 µg/ml) and this improved activity is suggested to be mostly due to punicalagin. 1,18-octadec-9-ene-dioate, stigmast-4-en-3-one, 5α-stigmastan-3,6-dione, triacontanol, sitostenone and β-sitosterol were found in antimycobacterial hexane extracts of the stem bark of both studied species. Of these compounds, 1,18-octadec-9-ene-dioate, stigmast-4-en-3-one, 5α-stigmastan-3,6-dione, triacontanol, sitostenone have not been previously identified in T. brownii and T. laxiflora. Moreover, both plant species contained friedelin, betulinic acid, β-amyrine and two unknown oleanane-type triterpenoids. Of the listed compounds, friedelin, triacontanol and sitostenone gave a MIC of 250 µg/ml against M. smegmatis, whereas stigmasterol and β-sitosterol gave MIC values of 500 µg/ml.
Conclusions:
Our results show that T. laxiflora and T. brownii contain antimycobacterial compounds of diverse polarities and support the traditional uses of various parts of T. laxiflora and T.brownii as decoctions for treatment of tuberculosis. Further investigations are warranted to explore additional (new) antimycobacterial compounds in the active extracts of T. laxiflora and T. brownii.
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Introduction
Tuberculosis (TB), is caused by the globally leading bacterial killer, Mycobacterium tuberculosis, and is becoming increasingly common worldwide due to international travel (WHO, 2006; Willcox et al., 2004) . Presently, TB is a major health hazard due to multidrug-resistant (MDR) and extensively-drug resistant (XDR) forms of M. tuberculosis which emerge specifically in poor societies due to inaccurate medication and poor living standards (WHO, 2013a; Zhao et al., 2014) . Among children, pregnant women and people suffering from immunodeficiency, the mortality rate due to TB is especially high (WHO, 2010) . In 2012, TB resulted in 1.3 million deaths and 8.6 million new TB cases (Zhao et al., 2014; WHO, 2010) . It is estimated that about 3.5% of the new cases and 20.5% of earlier treated have MDR-TB (WHO, 2014) . Besides, an estimated 9.6% of the MDR-TB cases have appeared to be of the XDR-TB form (WHO, 2013b) . One of the limitations to the eradication of TB is its ability to persist in the human lungs in a dormant state, and this state is especially resistant to anti-TB drugs and to the human immune system (Sala et al., 2014) . Latent infection is the major pool of worldwide TB cases and treatment of latent TB is therefore an important goal to eradicate the disease (Young et al., 2009; Abuhammad et al., 2012) .
Moreover, the six month long treatment regimens of TB, using rifampin, isoniazid, ethambutol and pyrazinamide, often gives severe side effects and is difficult to complete in impoverished areas with poor public health care systems. Treating resistant TB requires even longer treatment periods and more toxic therapies (Wivagg et al., 2014) .
The current number of new anti-TB candidates in the drug pipeline for combating TB is insufficient (Marrakchi et al., 2014; Zumla et al., 2013) . Therefore, the need to find and develop new anti-TB drugs is urgent (Shilpi et al., 2015) . In recent years there has been a renewed interest in the discovery of antimycobacterial agents from natural sources (Dashti et al., 2014; Santhosh and Suriyanarayanan, 2014; Shilpi et al., 2015) .
Africa has a rich tradition on the uses of medicinal plants for the treatment of tuberculosis and its symptoms and this ethnobotanical information could be used as a guideline to find new scaffolds for anti-TB drugs from African plants. In Africa there occurs an estimated 30 species of Terminalia and only a fraction of these species have been studied for their antimycobacterial effects and active compounds, although most of them have some uses for treatment of TB or its symptoms.
For example, antimycobacterial ellagic acid xyloside and punicalagin were found from T. superba (Kuete et al., 2010) ; acetone extracts of T. sericea inhibited the growth of M. tuberculosis H 37 Ra (Green et al., 2010) ; crude extracts of the leaves of T. glaucescens were active against M.
tuberculosis H 37 Rv (Nvau et al., 2011) ; the pentacyclic triterpene, friedelin, from T. avicennoides gave good growth inhibitory effects against M. bovis (Mann et al., 2011) .
Terminalia laxiflora (Engl. & Diels) and T. brownii (Fresen) (Comretaceae) are dry savanna woodland trees occurring commonly in the Sudano-Sahelian area of Africa (Foyet, 2013) .
Other additional geographical regions of occurrence for T. brownii include Nigeria, Congo, North
Tanzania and Kenya (Mosango, 2013) . T. laxiflora and T. brownii are customarily used by traditional medicinal practitioners (TMP) against cough, chest pain and fever, symptoms related to TB (Mohieldin et al., 2017; El Ghazali et al., 2003; Musa et al., 2011; El Ghazali et al., 1997; Salih personal communication, 2006 Salih personal communication, , 2012 Salih personal communication, and 2014 . In Sudan, traditional preparations of remedies from T. brownii and T. laxiflora include soaking fresh and/or dry plant material for one day in lukewarm tap water as well as boiling the plant material in water for a few minutes to prepare decoctions, or to infuse the plant material in freshly boiled water to produce a tea El Ghazali et al., 2003; Salih personal communication, 2006 Salih personal communication, , 2012 Salih personal communication, and 2014 . Despite of the frequent and various uses of T. brownii and T. laxiflora for the treatment of bacterial infections in traditional medicine, there are few studies available on their antimicrobial activities (Opiyo et al., 2011; Mbwambo et al., 2007) and to the best of our knowledge no studies have been conducted previously on the antimycobacterial effects of extracts and compounds of these plants.
Some research has been done on the phytochemistry of Terminalia laxiflora and T.
brownii. Medium polar to polar phenolic compounds, such as gallic acid, ellagic acid and its derivatives, gallotannins and the ellagitannins punicalagin, terchebulin, methyl-(S)-flavogallonate and its isomer have recently been characterized in the roots of both species and in the stem bark of T. brownii (Machumi et al., 2013; Yamauchi et al., 2016; Schrader et al., 2016; Salih et al., 2017) .
Moreover, terchebulin, flavogallonic acid dilactone and ellagic acid and its derivatives have been reported to occur in the stem wood of T. laxiflora (Ekong and Idemudia,1967; . In addition, the sterols β-sitosterol and stigmasterol as well as the triterpenoids betulinic acid, arjungenin, terminolic acid and monogynol A, the diterpenoid laxiflorin and terminalianone, a chromone, were reported from the stem bark of Terminalia brownii and T. laxiflora and the root bark of Terminalia laxiflora (Rashed et al., 2016; Machumi et al., 2013; Opiyo et al., 2010; Negishi, et al., 2011; Ekong and Idemudia, 1967) .
This study describes the growth inhibitory effects of extracts of a wide range of polarities from the stem bark, stem wood, roots, leaves and fruits of T. brownii and T. laxiflora on Mycobacterium smegmatis. Sephadex LH-20 and RP-18 TLC fractions, enriched in ellagitannins and ellagic acid derivatives, were also used in the screenings in order to investigate how these chromatographic purifications affect the capacity of the fractions to inhibit the growth of M.
smegmatis. The MIC values of some pure compounds occurring in the extracts were investigated in order to compare their activities to the extracts. UHPLC/Q-TOF MS, HPLC-DAD and GC/MS results on the molecular masses of ellagitannins, ellagic acid derivatives, triterpenes, sterols, fatty acids and fatty alcohol derivatives are presented. separated manually to stem wood, stem bark, roots, leaves and fruits and ground to fine powder using a hammer mill (mesh). This powder was used for extraction, antimycobacterial testing and phytochemical analysis.
Material and methods
Plant material
Extraction methods
Soxhlet extraction
Methanol was used in order to obtain crude extracts containing a broad class of compounds. 20 g of dried ground materials were extracted with 800 ml MeOH in a Soxhlet apparatus for 5 hours. The obtained extracts were cooled before transferring to a rotary evaporator (Heidolph VV2000), using a water bath not exceeding +40°C. The extracts were then freeze-dried in a lyophilizer for 1-2 days.
Sequential extraction and liquid partition
Sequential extraction and liquid partition was used to obtain extracts of various polarities in order to monitor compound classes responsible for antimycobacterial activity. In brief, for sequential extraction, 100 g of plant powder was defatted using hexane (1500 ml), whereafter the marc was extracted with dichloromethane or chloroform (1400 ml) followed by 80% methanol (800-1000 ml). For root bark, roots and leaves the marc was extracted with acetone (800-1000 ml) before using 80 % methanol. The 80 % methanol extraction was completed using a magnetic stirrer overnight at room temperature. The 80% methanolic extracts were fractionated with ethyl acetate (EtOAc) using liquid-liquid partition. Thus, the extractions and fractionations resulted in hexane, dichloromethane, chloroform, acetone, ethyl acetate and aqueous fractions. Ethyl acetate and aqueous fractions were concentrated to dryness using a rotary evaporator (Heidolph VV2000) at +40 º C. The rest of the fractions were dried at room temperature in a fume cabinet. All extracts were further freeze-dried in a lyophilizer
Decoctions, macerations and cold methanol extractions
Decoctions were prepared to resemble as closely as possible similar preparations customarily used by traditional healers in Sudan. 500 ml of water was added to 20 g of the plant powder, mixed carefully and brought to the boil. The decoction was centrifuged at 2000 rpm for 10-15 minutes (Eppendorf AG centrifuge 5810 R, Germany) and filtered using filter paper (Schleicher & Schuell,  150 mm, Germany), whereafter it was freeze-dried for two days. Macerations were prepared from 10-20 g of plant powder soaked in 300-500 ml cold water overnight. Cold methanol extractions were prepared according to a procedure identical to the macerations, using the same extraction time and dry material to solvent ratio (w/v).
Extracts resulting from the various extraction procedures described above were dissolved in methanol (medium-polar to polar extracts) or hexane (very non-polar extracts) to a concentration of 50 mg/ml and were used for primary antimycobacterial screening using an agar disk diffusion method. The yields resulting from each method of extraction are given in Fig. S8 and S9.
Chromatography
Sephadex LH-20 chromatography of a Terminalia brownii root extract
A root methanolic Soxhlet extract of Terminalia brownii was subjected to Sephadex LH-20 (Pharmacia, Uppsala) fractionation using size exclusion in order to separate tannins from non-tannin phenols in the extract (Hagerman, 2002; Saleem et al., 2002) . 200 mg dry root methanolic Soxhlet extract was dissolved in 10 ml of 80% (v/v) EtOH. The extract was centrifuged to avoid precipitation whereafter it was poured into a 50 ml volume plastic centrifuge tube (Eppendorf) containing 2.5 g Sephadex LH-20 (Uppsala, Pharmacia Biotech AB, Sweden). The
Sephadex LH-20 and the extract in the tube were mixed carefully, centrifuged at 3000 rpm for 3 min, whereafter the supernatant was collected. Extractions using 8-10 ml 80% (v/v) EtOH and centrifugations were repeated several times until the resulting supernatant changed color from yellow to clear and showed an absorbance close to zero at 280 nm. The "tannin fraction" (ET enriched fraction or acetone fraction) was released from the Sephadex LH-20 using 2  15 ml 70% acetone. The acetone extract was filtrated using double filter paper (Whatman) into a 100 ml rotary evaporation flask to be concentrated to dryness using a rotary evaporator. The 80 % EtOH fraction (containing a higher percentage of ellagic acid derivatives) was also reduced to dryness using a rotary evaporator. Both fractions were dissolved in 5 ml H 2 O before drying, using liquid nitrogen, whereafter the fractions were freeze-dried for two days. The freeze-dried fractions were dissolved in MeOH to make stock solutions of 1000 µg/ml for antimycobacterial testing and for phytochemical analysis (HPLC-DAD).
Preparative RP-18 TLC of a Terminalia laxiflora root extract
Preparative thin layer chromatography (TLC) was performed on glass-backed RP-18 F 254s TLC-plates (Merck, Darmstadt, Germany) to separate ellagitannin enriched fractions. 10 microliters of extracts and fractions (50 mg/ml) were applied equidistantly from each other and 1.5
cm from the bottom of the plate using a microcapillary pipette. 10 ml of freshly prepared methanol:
water: orthophosphoric acid (50:50:1, v:v:v) containing the fractions/ compounds was extracted with methanol whereafter the tubes were centrifuged for 10 min using 5000 rpm (Mini Spin®plus, Eppendorf, Germany). The supernatants were carefully transferred to new test tubes and evaporated to dryness in an evaporator (Concentrator Plus, Eppendorf). The dried fractions were dissolved in methanol to a concentration of 1000 µg/ml stock solutions used for antimycobacterial testing and for phytochemical analysis (HPLC-DAD).
Qualitative DPPH-TLC bioautography method
A thin-layer chromatography bioautography method (Wang et al., 2012) for in situ qualitative determination of antioxidative effects of compounds and fractions of T. brownii and T. laxiflora was used. Thin-layer chromatography was performed on aluminium-backed TLC plates (Merck, Darmstadt, Germany). 1 µl of extracts (50 mg/ml) were applied 1.5 cm from the bottom of the plate. Methanol: water: orthophosphoric acid (50:50:1,v:v:v) was used as eluent and development distance was 8-12 cm. The plates were left to dry for 30 min, wherafter they were photographed using Camaq Reprostar 3 TLC Visualizer documentation system at 366 and 254 nm.
After documentation, the plates were sprayed evenly with 0.2 % (w/v) 2,2-Diphenyl-1-picrylhydrazyl reagent in methanol (DPPH, Sigma-Aldrich), left to dry and quickly photographed in visible light. Antioxidative fractions/compounds on the plate appear yellow against a purple background. Ellagic acid, gallic acid, luteolin, corilagin and naringenin (Sigma-Aldrich) were used as standard compounds (Fig. S3 ). The spayed plates were compared to their unsprayed replicates as well as with standard compounds and their R f values in order to identify antioxidative compounds/fractions in extracts of T. brownii and T. laxiflora.
HPLC-UV/DAD method
A method described in Fyhrquist et al. (2014) and Salih et al. (2017) was used for the identification of polyphenols. An autosampler controlled by Agilent Chemstation software (Water Corp., Milford, USA) was used. A liquid chromatographic system was used consisting of a Waters 600 E pump and a controller coupled to a 991 PDA detector. Separations were made on a reversed phase Hypersil Rp C 18 column (length: 60 mm; ID: 2 mm). 10 μl of samples (2 mg/ml in 50% MeOH) were injected. Gradient elution was performed using two solvent systems: A) Aqueous 1.5% tetrahydrofuran + 0.25% orthophosphoric acid and B) 100 % MeOH. Flow rate was 2 ml/min.
UV fingerprint chromatograms were constructed at 220, 270, 280, 320 and 360 nm. UV λ absorption spectra of the compounds were recorded between 210 and 400 nm using Agilent Chemstation software. Phenolic compounds were compared to the computer compound library (Agilent Chemstation) and to the literature (Conrad et al., 2001; Pfundstein et al., 2010) .
UHPLC/ Q-TOF MS method
UHPLC-DAD (Model 1200 Agilent Technologies)-JETSTREAM/QTOFMS (Model 6340 Agilent Technologies) equipped with a 2.1  60 mm, 1.7 µm C 18 column (Agilent technologies) as described in Salih et al. (2017) was used for detecting the masses of polyphenolic compounds. Solvent A consisted of 1.5% tetrahydrofuran and 0.25% acetic acid in HPLC quality water and solvent B was 100% methanol. A gradient run was used as follows: from 0 to 1.5 min, B 0 %, from 1.5 to 3 min, 0 to 15% B, from 3 to 6 min, 10 to 30 % B, from 6 to 12 min, 30 to 50% B, from 12 to 20 min, 50 to 100% B, and from 20 to 22 min, 100 to 0% B. The qtof-mass spectra were acquired at the negative ion modes depending on the compounds, and a mass range from 100 to 2000 m/z was used. The ppm values describing the mass measurement error were calculated according to the below formula (Brenton and Godfrey, 2010) :
Difference between an individual measurement and the calculated value, Mi (in ppm, parts per million mass error) = (M measured -M calculated ) x 10 6 /M calculated Where M measured stands for the measured mass in Q-TOF and M calculated stands for the calculated mass according to the molecular formula of the compound. Since negative mode of Q-TOF was used, the mass of the hydrogen atom (1.0078) was subtracted from all the calculated masses. 
GC/MS
Gas chromatograph mass spectrometers (GC/MS)
The GC/MS HP6890 instrument consisted of an autosampler, a split/splitless injector, a column oven and a MS detector. The capillary column used was a RTX TM -5 fused-silica column
[crossbond 5% diphenyl and 95% dimethyl polysiloxane phase; 60 m, 0.32 mm id, 0.1 mm film, Restek Corp., Bellefonte, PA, USA]. The injector temperature was set at 275ᴼC. The GC oven temperature was initially adjusted at 150ᴼC held for 1 min then set to 275ᴼC at a rate of 15 ᴼC/min, and finally programmed to 310ᴼC at rate 5.00 ᴼC/min and held for 10 min. The actual injected volume of the sample was 2.0 µl. Helium was used as the carrier gas and its pressure was adjusted at 21.50 psi. In the MS, the interface and ion source temperatures were 280ᴼC and 230ᴼC, and electron impact ionization was used. Full scan mass spectra (80-650 m/z) were collected.
GC/MS data analysis
The non-polar compounds were identified by comparing with mass spectra of standard compounds and to literature (AOCS libid library, Goad and Akihisa, 1997 and Assimopoulou and Papageorgiou, 2005) as well as Wiley, NIST and Scifinder libraries of reference compounds. The peak area (%) and M + (the mass to charge for the molecular ion) of the compounds were reported.
Assays for measuring antimycobacterial activity
Agar disk diffusion
An agar disc diffusion assay according to Fyhrquist et al. (2014) was used for the primary antimycobacterial screening. Mycobacterium smegmatis ATCC 14468 was selected as test bacterium since it is known to have a similar drug sensitivity profile to M. tuberculosis and at the same time it is fast-growing and non-pathogenic (Newton et al., 2002 (50mg/ml) and rifampicin (10mg/ml, Sigma-Aldrich) were applied on sterile filter paper disks (Ø = 12.7 mm, Schleicher and Schuell 2668). The solvent from the filter papers containing the extracts and antibiotics was left to dry. Methanol and hexane were used as negative controls. Prior to incubation the petri dishes were kept in +4 °C to facilitate diffusion of the extracts into the agar.
The petri dishes were then incubated at +37 °C for five days. All extracts and antibiotics were tested in triplicate. The diameters of the zones of inhibition (IZ) were measured with a caliper under a petri dish magnifier and the mean of three replicate diameters ± SEM was calculated. Activity index of the plant extracts and fractions was measured in relation to rifampicin as in Fyhrquist et al. (2014) as follows:
AI (Activity index) = Inhibition zone of the plant extract/ Inhibition zone of rifampicin
Agar disk diffusion for MIC estimations
For some of the extracts MIC was difficult/impossible to determine using the microplate method due to extensive buildup of precipitation and in these cases the agar diffusion method described above was used. Two-fold dilutions from 5000 to 39.06 μg/ml for the plant extracts and from 1000 to 0.98 μg/ml for rifampicin were made in methanol or hexane. 200 µl of the dilutions were pipetted on filter paper disks (Ø = 12.7 mm, Schleicher and Schuell 2668) which were placed equidistantly on the petri dishes inoculated with M. smegmatis as described above. The petri dishes were incubated for five days in +37 °C, whereafter diameters of inhibition were measured as above. The approximate MIC was estimated as the lowest mean inhibitory concentration of triplicates giving a small, but visible inhibition zone around the filter paper disc.
Microplate broth dilution method
To determine the minimum inhibitory concentration (MIC) and the percentage inhibition of bacterial growth (inhibitory concentration IC) of those extracts giving the most prospective growth inhibitory activities in the primary screening agar diffusion assay, a modified microplate broth method according to Fyhrquist et al. (2014) and according to guidelines of the Clinical and Laboratory Standards Institute (2013) was used. M. smegmatis ATCC 14468 was grown on Löwenstein-Jensen agar slants for five days at +37C. A colony from the agar slant was transferred into Dubos broth (Difco) and the turbidity of the sample was measured at 625 nm using a spectrophotometer (UV-Visible Spectrophotometer, Pharmacia LKB-Biochrom 4060). The absorbance at 625 nm was adjusted to 0.1 (approx. 1.0×10 8 CFU/ml) using Dubos broth (Difco).
This suspension was diluted further so that the final number of cells in the inoculum was approximately 5.0 × 10 5 CFU/ml. 100 µl of this inoculum was added to the wells of the microplate (Nunc, Nunclone, Denmark). In addition 100 µl of two-fold dilutions of the plant extracts (9.76-5000 µg/ml) and of rifampicin (0.98-1000 µg/ml) in Dubos broth or 100 µl broth (growth control)
were added to the wells of the microplate, so that the final volume in each well was 200 µl. Thus, at the starting point of the experiment each well contained an inoculum of 2.5 × 10 5 CFU/ml. Plant extracts, fractions, pure compounds or rifampicin in broth without bacterial inoculum were used as sample controls. MeOH and hexane were used as solvent controls and did not affect the growth of M. smegmatis at 5 % (v/v) or less. The plates were incubated for four days at 37 C, whereafter turbidity of the wells at 620 nm was measured using a Victor 1420 microplate reader (Wallac, Finland). As described in the below formula, the results were measured as mean percentage inhibition compared to the growth control of three replicate samples  SEM. The minimum inhibitory concentration (MIC) was considered as the smallest concentration of the extracts, fractions, pure compounds and rifampicin inhibiting visible growth which was found to be equal to 90 % inhibition or more of the growth when measured spectrophotometrically at 620 nm.
% inhibition of growth (IC) = 100 (% growth of the growth control) -((GT A620 -SC A620 )/GC A620 )  100)
where GT A620 is the turbidity of the test well at 620 nm (plant sample, pure compound or antibiotic), SC A620 stands for the test sample negative control and GC A620 is the turbidity of the growth control at 620 nm (containing only bacterial cells).
Statistical analysis
The data from diameters of inhibition and the percentage inhibition of growth were expressed as mean ± SEM, obtained from three independent experiments, each sample performed in duplicate, triplicate or quadruplicate.
Results and discussion
General observations
A total of seventy-seven extracts from the roots, stem bark, stem wood, fruits and leaves as well as three chromatographic fractions from the roots of T. laxiflora and T. brownii were tested for their growth inhibitory effects against Mycobacterium smegmatis ATCC 14468. The roots of both species of Terminalia gave the best growth inhibitory effects, although nearly all extracts gave some activity, and growth inhibition was observed both for polar and non-polar extracts (Table   1 and 2). Our results on the good growth inhibitory effects of especially the root extracts of both species of Terminalia are in accordance with Mann et al. (2008) who reported that root extracts of Terminalia avicennoides give strong antimycobacterial effects.
Growth inhibition of medium-polar to polar extracts from various plant parts
Polar to medium polar extracts from the roots (methanol, acetone and ethyl acetate) of T. laxiflora gave lower MIC values (625-2500 µg/ml) than root extracts of similar polarities from T.
brownii (MIC 2500-5000 µg/ml) ( Table 2) , although the zones of inhibition were larger for the root extracts of T. brownii (Table 1) . Interestingly, cold water extracts (macerations) and decoctions of the roots of both species gave good antimycobacterial effects in terms of the sizes of their inhibition zones (Table 1) . Notably, when using methanol Soxhlet extraction, the extraction yield for the root bark was especially beneficial for T. brownii, giving a 78.2% yield compared to 28.8% and 43.4%
yields, respectively, for a wood and a stem bark extract (Fig. S8 a) . For T. laxiflora, however, the roots gave smaller extraction yields (34%) than the stem bark (41.1%) when using Soxhlet methanol extraction (Fig. S8 a) . For both species of Terminalia, the yields of decoctions and macerations of the roots were lower than the yields obtained with methanol Soxhlet extraction ( Fig.   S8 b) which means that the traditional procedure of preparing these plants for medicine gives a fairly low yield of antimycobacterially active compounds. Our results justify the traditional uses of the roots of T. laxiflora for treatment of tuberculosis and cough (Foyet and Nana, 2013 ), but we suggest that ethanol extracts could be used instead of macerations and decoctions. The roots of T.
brownii are only reported to be used for allergic reactions (Mosango, 2013) , and therefore our results now suggest that the roots of this species also could have uses for the treatment of TB.
When compared to the root extracts, the extracts of stem wood and bark of both species of Terminalia in general gave smaller zones of inhibition (Table 1) . Interestingly, decoctions of the stem wood of T. brownii and T. laxiflora gave good growth inhibition whereas decoctions of the bark of both species showed only slight activity. Thus, our results justify the use of decoctions and infusions of the stem wood of T. brownii for treatment of fevers, colds and chest complaints, including tuberculosis (Burkil, 1994) . Here must be noted that fairly low yields of 2.8 and 6 % resulted from hot water extraction of the stem wood of T. brownii and T, laxiflora, respectively (Fig. S8 b) . Thus, again, ethanol might be a better solvent for the preparation of traditional medicine from the stem wood of these species to treat TB, since the yields resulting from methanol Soxhlet extraction were higher than for hot water extraction (Fig. S8 a) .
In addition to the roots and stem also the leaves of T. brownii and T. laxiflora contain antimycobacterial compounds and we found that ethyl acetate extracts of the leaves of both species gave large zones of inhibition (Table 1) . We found, however, that the yields resulting from ethyl acetate extraction, used as one of the solvents in our sequential extraction procedure, were rather low for both species of Terminalia (Fig. S9 a and S9 b) We hypothesize that the variation in antimycobacterial potency between extracts of different plant parts of T. laxiflora and T. brownii could be due to the ratios of the various polyphenolic compounds, especially that of ellagitannins in these organs, so that the optimum ratio might be present in the roots which gave the most prospective growth inhibitory effects in our study. Roots in general have been found to contain higher levels of antimicrobial defense compounds when compared to other organs (Balmer and Mauch-Mani, 2013) . It is possible that some of the compounds in the roots of T. laxiflora and T. brownii (ellagitannins and other phenolic compounds) act synergistically with each other to maximize the defense capacity of the roots against pathogenic soil bacteria and fungi (Balmer and Mauch-Mani, 2013 ).
Leaf, stem bark and root extracts of T. laxiflora and T. brownii have been reported to give growth inhibitory effects against some gram-negative and gram-positive bacteria (Abd alla et al., 2013; Machumi et al., 2013; Mbwambo et al., 2007; Fasola et al., 2013; Salih et al., 2017) , but this is the first report on their good antimycobacterial effects.
Growth inhibition of an ellagitannin enriched RP-18 TLC fraction from an ethyl acetate extract of the roots of T. laxiflora
Based on good growth inhibitory results from the primary screening, an ethyl acetate extract of the roots of T. laxiflora was chosen for further fractionation using preparative reversed phase thin layer chromatography (RP-18 TLC) in an attempt to separate antimycobacterial fractions and compounds from this extract, with special emphasis on ellagitannins. We have previously reported that the crude ethyl acetate extract of the roots of T. laxiflora contains a high concentration and diversity of unknown ellagitannins, along with punicalagin, corilagin and its derivative (Salih et al., 2017 ; Table S3 ). reported on the presence of flavogallonic acid dilactone and terchebulin in a methanolic extract of the stem wood of T. laxiflora, but we found that ethyl acetate extracts of the stem wood and roots of T. laxiflora were devoid of these ET:s.
Our TLC fractionation of an ethyl acetate extract of the roots of T. laxiflora resulted in altogether seven fractions (Fig. S1 ). Of these fractions, only fractions 5 (R 5 ) and 6 (R 6 ) were available in high enough concentrations to be tested for their antimycobacterial effects. These fractions 5 (R 5 ) and 6 (R 6 ), showed a significant enrichment of ellagitannins, and especially in punicalagin, compared to the ethyl acetate extract (Table S3) . Since fractions 5 (R 5 ) and 6 (R 6 ) were very similar to each other, both containing punicalagin as the main compound, only the other one (fraction 5) was investigated for its antimycobacterial effects. The MIC of fraction 5 (R 5 ) was 500 µg/ml and thus 2.5 times lower than the MIC (1250 µg/ml) for the crude ethyl acetate extract ( Table   2 ). The compounds in the thin layer chromatography fraction 5 (R 5 ) were tentatively identified using HPLC-DAD data, comparing retention times and UV  max data to the corresponding compounds in the crude ethyl acetate extract (Table S3 ). According to this data, fraction 5 (R 5 ) contained a much higher concentration of punicalagin (5), exhibiting an HPLC-DAD peak area of 29.62 % compared to a peak area of 12.99 % for punicalagin in the crude ethyl acetate extract (Table S3) . Therefore, most of the antimycobacterial potential of fraction 5 is suggested to be attributed to punicalagin. Punicalagin has been found to totally inhibit the growth of M. tuberculosis typus humanus at concentrations higher than 600 µg/ml as well as to inhibit the growth of a patient strain of M. tuberculosis at concentrations higher than 1200 µg/ml and was the first ellagitannin reported to possess antimycobacterial effects (Asres et al., 2001) . Punicalagin contains two galloyl groups, the number and position of which are known to be related to the antibacterial potential of ellagitannins (Shimozu et al., 2017) . Davidiin, a small ellagitannin from Davidia involucrata, containing three galloyl groups, was found to be highly antibacterial against MRSA and VRE (MIC 16-64 µg/ml), compared to ellagitannins containing only hexahydroxy-(HHDP) and dehydrohexahydroxydiphenoyl (DHHDP) groups but lacking galloyl groups (Shimozu et al., 2017).
Moreover, ellagitannin enriched extracts have been found to disrupt the membrane function in bacteria, eventually resulting in cell lysis (Shimozu et al., 2017; Todorovic et al., 2017) .
We found that in fraction 5 (R 5 ), corilagin (4) (R f value 0.549; Fig.S3 ) occurred in relatively higher concentrations, giving a peak area of 7.31 % compared to 6.69 % in the crude ethyl acetate extract of T. laxiflora (Table S3) . Therefore, we investigated if this ellagitannin gives growth inhibitory effects against M. smegmatis. We found, however, that corilagin gave moderate inhibitory effects against M. smegmatis with a rather high MIC value of 1000 µg/ml (Table 2 ).
According to the discovery that the number and position of galloyl groups are important to the antibacterial activity of polyphenols (Taguri et al., 2004; Shimozu et al., 2017) , already mentioned, corilagin should be more antibacterial than punicalagin since it contains one more galloyl group than punicalagin. However, this seems not to be true for mycobacterial strains, according to the MIC results for punicalagin (MIC ˃600 µg/ml) reported by Asres et al. (2001) (Courtney et al., 2015) .
Therefore, we investigated the reducing capacity of compounds (ET:s and other polyphenols) in the crude ethyl acetate extract of T. laxiflora using a TLC-DPPH qualitative method (Fig. S1 D) . In addition we compared a decoction to the ethyl acetate extract, since this preparation is frequently used in traditional medicine (Fig. S2 D) . Moreover, the R f values and reducing capacity of the pure standard compounds of corilagin, gallic acid and ellagic acid were compared to the corresponding compounds in the crude extracts (Fig. S3) . We observed that several compounds in the ethyl acetate extract and in the decoction gave strong antioxidative effects as demonstrated by a colour change of the DPPH reagent from purple to yellow for antioxidative compounds on the thin layer plates (Fig.   S1 , S2 and S3). Strong antioxidative effects were observed for corilagin, ellagic acid and gallic acid in the crude ethyl acetate extract and the decoction (Fig. S1, S2 and S3). Our results are in accordance with Courtney et al. (2015) who report on both good antimicrobial and antioxidative effects of ellagitannin enriched extracts of Terminalia ferdinandiana, although these two properties
were not correlated to each other in their report. Especially corilagin has been reported to give good antioxidative effects with an IC 50 value of 53 µg/ml (Anokwuru et al., 2015) . Therefore, we suggest that the antimycobacterial properties of decoctions of T. laxiflora used in traditional medicine, could be due to ellagitannins and partly via their antioxidative effects.
In conclusion, our results justify the use of standardized water extracts and decoctions of T. laxiflora, enriched with ellagitannins, for the treatment of tuberculosis in African traditional medicine. In Africa all parts of T. laxiflora are used for treatment of TB and cough (Foyet and Nana, 2013) , and our results demonstrate now that especially the roots should be used for preparation of traditional medicine for treatment of TB. Care has to be taken when using extracts enriched with punicalagin, however, since high concentrations of punicalagin have been found to cause liver necrosis in mice (Doig et al., 1990) .
Growth inhibition of Sephadex LH-20 fractions of a root extract of T. brownii
Sephadex LH-20 fractionation of a methanolic root extract of T. brownii was used to study the effects of ellagitannin and ellagic acid derivative enrichment on the MIC against M.
smegmatis. Two fractions resulting from this purification, an acetone and an ethanol fraction ( Fig.   1 ), were tested for their growth inhibitory effects against M. smegmatis. Our results demonstrate that, in comparison to the crude methanol extract which gave a MIC of 5000 µg/ml, the acetone wash, enriched with ellagitannins, gave a MIC of 62.5 µg/ml (Table 2 , Fig.1B ). Sephadex LH-20 purification thus results in a significant increase in antimycobacterial activity of the acetone soluble fraction. Moreover, in comparison, the MIC for rifampicin using microplate dilution method was 3.9 µg/ml (Table 2) . We used HPLC-DAD analysis for tentative identification of compounds in the Sephadex LH-20 fractions. Retention times and UV absorption maxima of the compounds in the fractions were compared to compounds in the crude methanolic Soxhlet extract. We found that the acetone wash was enriched with methyl (S)-flavogallonate (9) (peak area % 14.30, Rt 12.37 min) and its isomer (5) (peak area % 12.21, Rt 8.56 min) as well as an unknown ellagitannin (10) at Rt 15.08 min (peak area % 25.64) (Fig. 1B and Table S4 ). Therefore, the antimycobacterial activity of the acetone wash is suggested to be mostly attributed to these ellagitannins. This fraction also contained a high number of other, unknown polar ET:s (Rt 8.04-13.94 min). These ellagitannins might act synergistically with each other to improve the antimycobacterial effects of this fraction.
Methyl (S)-flavogallonate has been reported to occur in various parts of other Terminalia
species, such as in the leaves of T. myriocarpa (Marzouk et al., 2002) as well as in the fruits of T. chebula, T. bellerica and T. horrida (Pfundstein et al., 2010) and in the galls of T. chebula (Manosroi et al., 2013) . Methyl (S)-flavogallonate contains gallic acid moieties esterified to a flavogallonoyl unit (Marzouk et al., 2002) . Also castalagin, which is structurally related to methyl (S)-flavogallonate, contains a flavogallonoyl unit participating in the C-glycosidic linkage (Yoshida et al., 1992) . Castalagin has been found to be strongly antibacterial against S. aureus, Salmonella This would apply to methyl (S)-flavogallonate which contains four pyrogallol units. To the best of our knowledge the antimycobacterial effects of methyl (S)-flavogallonate has not been evaluated.
Our results warrant further studies on the growth inhibitory effects of purified methyl (S)-flavogallonate, its isomer as well as of the unknown ellagitannin at Rt 15.08 min (Table S4 and Fig.   1 ; A, B and C).
We found that also the ethanol fraction (Fig. 1C ) was more growth inhibitory than the crude methanol extract of the roots of T. brownii and gave a MIC value of 125µg/ml compared to 5000 µg/ml for the crude methanol extract (Table 2) . We found that this fraction was enriched especially in ellagic acid (14) (Table S4) . Moreover, the isomer of methyl (S)-flavogallonate (5)
was also found to be present in higher concentrations than in the acetone wash (Table S4 , Fig. 1C ).
In addition the ethanol wash contained an acetylated ellagic acid derivative (18) and methyl ellagic acid xyloside (13), which were absent in the acetone wash (Table S4 and Fig. 1C ). Some ellagitannins with long retention times of 28.3 (16), 28.9 (17) and 35.7 min (19) (two ET:s in one peak) were found in the ethanol fraction but were absent from the acetone fraction (Fig. 1 , Table   S4 ). On the other hand the unknown ellagitannin (10) at retention time 15.6 min was present in significantly smaller concentration (8.09% peak area) in the ethanol wash compared to the acetone wash (25.64% peak area) (Table S4 , Fig. 1 ; B and C). It seems from our result that the acetone wash contains the optimal ratio of this ellagitannin (10) together with methyl (S)-flavogallonate (9) and its isomer (5), which are suggested to be important for strong antimycobacterial activity. The good growth inhibitory effects of the ethanol wash is instead suggested to be due to a combination of ellagitannins and ellagic acid derivatives. were lower than those of isoniazid against some clinical strains of M. tuberculosis. In contrast to this result we found that ellagic acid gave a MIC of 500 µg/ml against M. smegmatis (Table 2) .
Therefore, it seems that ellagic acid should be combined with a sugar molecule and/or possess methyl groups to become more active. We suggest that the good growth inhibitory effects of the ethanol fraction of the roots of T. brownii might be due to ellagic acid xyloside and methyl ellagic acid xyloside. Ellagic acid derivatives and ellagic acid itself have been found to bind to proteins and in this way inactivate microbial adhesions, membrane transport proteins and enzymes (Haslam, 1996) . Ellagic acid derivatives such as 3,3′-di-O-methylellagic acid is also known to interfere with the biosynthesis of mycolic acid, the main constituent of the mycobacterial cell wall (Kondo et al., 1979) . Ellagic acid derivatives are considered to be important models for the development of new future anti-TB drugs since molecular docking studies on the effects of ellagic acid derivatives on enzymes important to the mycobacterial cell wall biogenesis have revealed ellagic acid based molecules, such as pteleoellagic acid, with promising activities (Shilpi et al., 2015) .
Our results show that Terminalia brownii could be a good source of new ellagic acid derivatives and ellagitannins with antimycobacterial potential and more studies are warranted on the antimycobacterial activity of isolated ellagic acid derivatives and ellagitannins from this species.
Growth inhibition of lipophilic extracts
As shown in Table 1 , since decoctions also contain nonpolar compounds such as triterpenes and free fatty acids which we have found to be present in the hexane extracts of these species (Table 5 , Fig. 2, 3 and S7). Here must be noted briefly, that the yields of extraction of hexane extracts of the stem bark and wood of both T. brownii and T. laxiflora is typically very low, compared to yields given by more polar solvents such as methanol (Fig. S8 a) .
Thus, it might be difficult to isolate antimycobacterial compounds from these extracts. In contrast to the hexane extracts of the stem bark and wood of T. laxiflora and T. brownii, we observed no growth inhibitory activity for the hexane extracts of the leaves of these species (Table 1) .
Our GC/MS analysis of the antimycobacterially active hexane extracts of the stem bark of T. laxiflora and T. brownii, resulted in the identification of thirty compounds, among which five triterpenes, three steroids, four long-chain fatty acids and three fatty alcohols were characterized (Table 5 , Fig. 2 and 3) . The similar qualitative composition might explain the similarities we have observed in antimycobacterial activities for the two hexane extracts of the stem bark of T. laxiflora and T. brownii, both giving a MIC value of 2500 µg/ml (Table 2, Fig. 2 ).
The following long-chain fatty acids were characterized for the first time in T. laxiflora and T. brownii and have to the best of our knowledge not previously been detected in the genus Terminalia (Table 5 and Fig. 2, 3 and S7); (1) 1,18-octadec-9-ene-dioate (C18:1), (2) tetracosanoic acid (syn. lignoceric acid) (C24:0), (3) hexacosanoic acid (syn. cerotic acid) (C26:0) and (5) octacosanoic acid (C28:0). Unsaturated fatty acids are known to possess antibacterial (Zheng et al., 2005) and antimycobacterial effects, such as linoleic acid, which gave a MIC of 2 µg/ml against Mycobacterium aurum (Seidel and Taylor, 2004) . The growth inhibitory activities of fatty acids have been found to vary with chain length and degree of unsaturation, so that chain lengths of 14 C-atoms seem to be optimal and a high degree of unsaturation renders fatty acids more active (Kondo and Kanai, 1977; Luo et al., 2011; Seidel and Taylor, 2004) . The unsaturated fatty acid (1), containing one double bond, was present in high concentrations especially in T.
brownii, but also in T. laxiflora (Table 5 and Fig. 2, 3 and S7) and is therefore suggested to account for some of the antimycobacterial effects we have seen in hexane extracts of these species. The other saturated fatty acids (2), (3) and (5) present in T. brownii and T. laxiflora are suggested to be less active accordingly. We tested the growth inhibitory activity of some saturated fatty acids, such as stearic (C18:0) and behenic acid (C22:0), which we have found to occur in chloroform and dichloromethane extracts of the stem bark of both Terminalia species and which we assume to be present in minute quantities also in the hexane extracts, and found that they did not give any growth inhibition at concentrations of 1000 µg/ml (Table 2) . These fatty acids are also known to be present in other species of the genus Terminalia (de Gouveia Baratelli et al., 2012; Kim et al., 2006; Onial et al., 2014) . Our results on behenic and stearic acid antimycobacterial activity supports earlier findings that saturated fatty acids with chain lengths shorter or longer than C14:0 are not antimycobacterial (Kondo and Kani, 1977; Seidel and Taylor, 2004) .
To the best of our knowledge research on fatty acids from native African Terminalia species is scanty, but there is a rich body of literature concerning fatty acid composition in
Terminalia chebula seed oil (Janporn et al., 2015; Onial et al., 2014; Hosamami, 1994) . No literature on the antimycobacterial effects of these fatty acids does exist, however. The amphiphilic architecture of fatty acids, consisting of a polar head group and flexible hydrophobic tail, make them an interesting group of antimycobacterial molecules, killing mycobacteria by inhibiting the biosynthesis of mycolic acid, an important constituent of the mycobacterial cell wall (Rugutt and Rugutt, 2012; Zheng et al., 2005) . Therefore, further research on the antimycobacterial effects of fatty acids isolated from T. brownii and T. laxiflora are warranted. Owing to the almost certain presence of fatty acids in hot water decoctions of these species, the frequently used traditional preparation of these plants, it would be important to test individual fatty acids in these decoctions for antibacterial and antimycobacterial potency.
The fatty alcohols octacosanol (4), triacontanol (6) and dotriacontanol (10) were reported for the first time in the stem bark of T. laxiflora and T. brownii (Table 5 and Fig. 2, 3 and S7). Octacosanol (4) and triacontanol (6) occurred in higher concentrations in T. laxiflora than in T.
brownii (Table 5 and Fig. 2) . We investigated the growth inhibitory effects of pure triacontanol which gave a MIC value of 250 µg/ml against M. smegmatis (Table 2) . Although the stem bark of T. laxiflora contained a higher concentration of triacontanol than the stem bark of T. brownii, the nhexane extracts of both species gave the same MIC value of 2500 µg/ml against M. smegmatis. This means that the precise concentration of triacontanol might not be critical for the antimycobacterial activity of these extracts, but maybe merely the presence of this compound, in order to contribute to the overall activity of the extracts. Also, it must be emphasized here, that two different methods, the microplate dilution and the agar diffusion were used for the pure compounds and extract, respectively, thus explaining the high relative differences in the MIC values. Some plant derived fatty alcohols are known to give potent antimycobacterial effects, such as phytol, which gave a MIC value of 2 µg/ml against M. tuberculosis H37Rv (Rugutt and Rugutt, 2012) .
We characterized β-sitosterol (7), stigmast-4-en-3-one (sitostenone) (9) and 5α-stigmastan-3,6-dione (13) from the hexane extracts of the stem bark of T. laxiflora and T. brownii, by comparison of their mass spectra with Wiley Natural Library and standard compounds (Table 5 and Fig. 3 ; f, h and i). To the best of our knowledge 5α-stigmastan-3,6-dione (13) has not been previously found in the genus Terminalia and moreover, antimycobacterial potency of this compound has not been elucidated. β-sitosterol was present in significantly higher concentrations in T. brownii when compared to T. laxiflora (Table 5 and Fig. 2 ). We found that β-sitosterol as well as the chemically closely related stigmasterol, the later of which we have found in the leaves of T.
brownii and T. laxiflora, both gave a MIC of 500 µg/ml against M. smegmatis (Table 2) . β-sitosterol from hexane extracts of Morinda citrifolia showed anti-tubercular activity with a MIC of 128 μg/mL against M. tuberculosis H37Rv (Saludes et al., 2002) . These differences in MIC might be explained by the uses of different mycobacterial strains, M. tuberculosis H37Rv being more sensitive than M. smegmatis against some antimycobacterial agents (Zhang et al., 2003) . A recent study by Edilu et al. (2015) , demonstrated large inhibition zones of β-sitosterol isolated from
Caylusea absyssinica (Resedaceae) against a wide range of bacteria, among them Salmonella typhimurium and Pseudomonas aeruginosa.
Earlier, β-sitosterol has been found in the root bark of T. laxiflora (Ekong and Idemudia, 1967) and stem bark of T. brownii (Machumi et al., 2013; Opiyo et al., 2011) , and in the fruit of Terminalia glaucescens, T. ivorensis, T. chebula and T. phanerophlebia (Bulama et al., 2015; Bag et al., 2013; Nair et al., 2012; King et al., 1955) . Recently, stigmasterol has been discovered in Terminalia mantaly (Tchuenmogne et al., 2017) . Moreover, β-sitosterol and sitostenone have been described in the stem bark of Terminalia sericea (Nkobole et al., 2011) .
Sitostenone from Rhizoctonia solani gave antibacterial activity with half maximal inhibitory concentration (IC 50 ) of 109.9 μg/mL against Pseudomonas lachrymas (Liang et al., 2015) .
According to the mass fragmentation pattern and comparing to the Wiley Natural Library, standard compounds and to Goad and Akihisa (1997) and Assimopoulou and Papageorgiou (2005) , a total of five triterpenes were characterized from the hexane extracts of the stem bark of T.
brownii and T. laxiflora (Table 5 and Fig. 2 , 3g and S7); β-amyrine (8), friedelin (syn; friedelin-3-one, friedelanone) (11), betulinic acid (12) and two oleanane-type triterpenoids (14) and (15).
Friedelin was quantitatively the main compound in hexane extracts of both Terminalia species (Table 5 and Fig.2, 3g and S7). There are no previous reports on the occurrence of friedelin in T.
brownii and T. laxiflora. Friedelin has been found in various parts of other species of Terminalia, such as the stem bark of Terminalia mollis (Liu et al., 2009 ) and the trunk bark of T. glabrescens (Garcez et al., 2003) . Friedelin, isolated from the root bark of Terminalia avicennioides, gave a MIC of 4.9 μg/ml against the Bacillus Calmette Guerin tuberculosis vaccine, consisting of weakened Mycobacterium bovis (Mann et al., 2008; Mann et al., 2011) . In another investigation friedelin gave a MIC of 128 µg/ml against M. tuberculosis (Higuchi et al., 2008b) . In our screening, however, we found that friedelin only moderately inhibited the growth of M. smegmatis with a MIC of 250 µg/ml ( Besides, friedelin has been found to give broad spectrum antibacterial effects against both grampositive and gram-negative bacteria with MIC values ranging from 2.44 -78.12 µg/ml (Kuete et al., 2007; Wang et al., 2014) . We suggest that friedelin might contribute significantly to the antimycobacterial effects of the hexane extracts of T. brownii and T. laxiflora.
β-amyrine (8) has been identified in other Terminalia species, such as T. ivorensis (King et al., 1955) and T. glaucescens (Atta-ur-Rahman et al., 2002) . β-amyrine, isolated from a chloroform fraction of the leaves of Byrsonima fagifolia gave potent antitubercular activity with a MIC of 31.5 μg/mL against M. tuberculosis H37Rv (Higuchi et al., 2008a) . Therefore, even though β-amyrine is present only in small quantities in the hexane extracts of the stem bark of T. brownii and T. laxiflora (Fig. 2, S7 ), this triterpene could still contribute to the good overall antimycobacterial effect of these extracts.
We found that betulinic acid (12) was present in minute quantities in T. laxiflora and T. brownii (Fig. 2) . Betulinic acid has previously been described in the stem bark of T. brownii and was found to inhibit the growth of Streptomyces ipomaea (Opiyo et al., 2011) . To the best of our knowledge, this is the first report on the occurrence of betulinic acid in T. laxiflora. Betulinic acid is also known from the barks of Terminalia catappa (Pertuit et al., 2015) and was found to give some growth inhibition against M. tuberculosis with a MIC of 400 µg/ml and an IC50 of 84μg/ml . Therefore, betulinic acid might contribute to the antimycobacterial activity of the hexane stem bark extracts of T. laxiflora and T. brownii.
Lastly, we found two oleanane-type triterpenes (14 and 15) in the hexane extracts of the stem bark of T. brownii and T. laxiflora (Table 5 and Fig. 2 ). To the best of our knowledge oleanane-type triterpenoids have not been reported before in T. laxiflora. However, a recent study by Machumi et al. (2013) , has reported on the occurrence of an oleanane-type triterpenoid in the stem bark of T. brownii. In addition, several authors have reported on oleanane-type triterpenoids in other Terminalia species (Elsayed et al., 2015; Zhang et al., 2015; Aiyelaagbe et al., 2014; Kakoli et al., 2005; Garcez et al., 2003; Anjaneyulu et al., 1986) . Oleanolic acid from Lantana hispida inhibited the growth of M. tuberculosis with a MIC of 25 µg/ml (Jesus et al., 2015) . Oleanane-type triterpenoids were found to affect peptidoglycan metabolism in Listeria monocytogenes (Kurek et al., (2010) . Morover, oleanane-type triterpenes have been found to suppress enzymatic function in the mycobacterial cell and to increase free radical molecules (Podder et al., 2015 and López-García et al., 2015) . Generally, lipophilic terpenoids affect the membrane function (Aleksic and Knezevic, 2014; Mochizuki and Hasegawa, 2006) . Therefore, the two oleanane-type triterpenes (14 and 15)
we have found in T. brownii and T. laxiflora should be investigated for their cell wall synthesis inhibiting and membrane affecting properties in mycobacterial species. Peptidoglycan is a highly interesting target for new antimicrobials.
Conclusions
We hereby report on the chemical structures of forty-five compounds from the stem bark, stem wood and the roots of T. laxiflora and T. brownii. Ellagitannins, ellagic acid and its derivatives as well as fatty acids, fatty alcohols, steroids and triterpenes present in extracts of these species could have potential as antimycobacterial leads and TB drug adjuvants. Our results support the traditional uses of T. brownii and T. laxiflora as decoctions for treatment of tuberculosis and cough. Therefore, further research is needed on optimization and standardization of the phytochemical composition of extracts of the studied species for more effective and safer use in traditional medicine.
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